PTB-700

N/A

Report date: 2026/05/22 20:01:29

NME

Base Information

Drug NamePTB-700

Drug Alias NamePTB-700

ClassificationSmall molecules > Molecular GlueBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionEukaryotic peptide chain release factor GTP-binding subunit ERF3A modulators

TargetsEukaryotic peptide chain release factor GTP-binding subunit ERF3A

Therapy Area/IndicationsMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesProtier Biotech Inc

China Registration ClassN/A

Develop Information

Active CompaniesProtier Biotech Inc

Inactive CompaniesN/A

Active IndicationsMultiple Myeloma

Inactive IndicationsN/A

Other Information

ATC CodeN/A